Cargando…

Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro

Bone void fillers (BVFs) containing calcium sulfate, tricalcium phosphate (TCP), and hydroxyapatite can be loaded with antibiotics for infection treatment or prevention under surgeon-directed use. The aim of this study was to characterize the handling and elution properties of a triphasic BVF loaded...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Michael, Ahmed, Hamza, Pace, Leslie, Minter, Jon, Neel, Michael, Jennings, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306754/
https://www.ncbi.nlm.nih.gov/pubmed/30248929
http://dx.doi.org/10.3390/jfb9040055
_version_ 1783382849466925056
author Harris, Michael
Ahmed, Hamza
Pace, Leslie
Minter, Jon
Neel, Michael
Jennings, Jessica
author_facet Harris, Michael
Ahmed, Hamza
Pace, Leslie
Minter, Jon
Neel, Michael
Jennings, Jessica
author_sort Harris, Michael
collection PubMed
description Bone void fillers (BVFs) containing calcium sulfate, tricalcium phosphate (TCP), and hydroxyapatite can be loaded with antibiotics for infection treatment or prevention under surgeon-directed use. The aim of this study was to characterize the handling and elution properties of a triphasic BVF loaded with common antibiotics. BVF was mixed with vancomycin and/or tobramycin to form pellets, and the set time was recorded. A partial refreshment elution study was conducted with time points at 4, 8, and 24 h, as well as 2, 7, 14, 28, and 42 days. Effects on dissolution were evaluated in a 14-day dissolution study. Set time increased to over 1 h for groups containing tobramycin, although vancomycin had a minimal effect. Pellets continued to elute antibiotics throughout the 42-day elution study, suggesting efficacy for the treatment or prevention of orthopedic infections. BVF containing vancomycin or tobramycin showed similar dissolution at 14 days compared to BVF without antibiotics; however, BVF containing both antibiotics showed significantly more dissolution.
format Online
Article
Text
id pubmed-6306754
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63067542019-01-02 Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro Harris, Michael Ahmed, Hamza Pace, Leslie Minter, Jon Neel, Michael Jennings, Jessica J Funct Biomater Article Bone void fillers (BVFs) containing calcium sulfate, tricalcium phosphate (TCP), and hydroxyapatite can be loaded with antibiotics for infection treatment or prevention under surgeon-directed use. The aim of this study was to characterize the handling and elution properties of a triphasic BVF loaded with common antibiotics. BVF was mixed with vancomycin and/or tobramycin to form pellets, and the set time was recorded. A partial refreshment elution study was conducted with time points at 4, 8, and 24 h, as well as 2, 7, 14, 28, and 42 days. Effects on dissolution were evaluated in a 14-day dissolution study. Set time increased to over 1 h for groups containing tobramycin, although vancomycin had a minimal effect. Pellets continued to elute antibiotics throughout the 42-day elution study, suggesting efficacy for the treatment or prevention of orthopedic infections. BVF containing vancomycin or tobramycin showed similar dissolution at 14 days compared to BVF without antibiotics; however, BVF containing both antibiotics showed significantly more dissolution. MDPI 2018-09-21 /pmc/articles/PMC6306754/ /pubmed/30248929 http://dx.doi.org/10.3390/jfb9040055 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Harris, Michael
Ahmed, Hamza
Pace, Leslie
Minter, Jon
Neel, Michael
Jennings, Jessica
Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
title Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
title_full Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
title_fullStr Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
title_full_unstemmed Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
title_short Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro
title_sort evaluation of antibiotic-releasing triphasic bone void filler in-vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306754/
https://www.ncbi.nlm.nih.gov/pubmed/30248929
http://dx.doi.org/10.3390/jfb9040055
work_keys_str_mv AT harrismichael evaluationofantibioticreleasingtriphasicbonevoidfillerinvitro
AT ahmedhamza evaluationofantibioticreleasingtriphasicbonevoidfillerinvitro
AT paceleslie evaluationofantibioticreleasingtriphasicbonevoidfillerinvitro
AT minterjon evaluationofantibioticreleasingtriphasicbonevoidfillerinvitro
AT neelmichael evaluationofantibioticreleasingtriphasicbonevoidfillerinvitro
AT jenningsjessica evaluationofantibioticreleasingtriphasicbonevoidfillerinvitro